Background. Loss of function mutations of thyrotropin receptor (TSHR) are one of the main causes of congenital hypothyroidism (CH). As for many disease-associated GPCRs, these mutations often affect the correct trafficking and maturation of the receptor, thus impairing the expression on the cell surface. Indeed, several retained GPCR mutants are able to effectively bind their ligands and to transduce signals when they are forced to the cell surface by degradation inhibition or by treatment with chaperones. Despite the large number of well-characterized retained TSHR mutants, no attempts have been made for rescue. Furthermore, little is known about TSHR degradation pathways. We hypothesize that, similarly to other GPCRs, TSHR retained mutants may be at least partially functional if their maturation and membrane expression is facilitated by chaperones or degradation inhibitors. Methods. We performed in silico predictions of the functionality of known TSHR variants and compared the results with available in vitro data. Western blot, confocal microscopy, ELISAs and dual luciferase assays Thyroid